Navigation Links
Volcano Corporation Announces Upcoming Presentation of Late-Breaking Clinical Trial Results and FFR Product Launch at TCT 2011
Date:11/4/2011

SAN DIEGO, Nov. 4, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guidance therapy tools designed to enhance the treatment of coronary and peripheral vascular disease, today announced that results from the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) clinical trial, sponsored by Volcano, will be presented in a Late-Breaking Session at Transcatheter Cardiovascular Therapeutics (TCT 2011), which is taking place from November 7-11 in San Francisco.

Volcano also announced it is launching a new fractional flow reserve (FFR) pressure wire, the PrimeWire PRESTIGE™ PLUS, Volcano's newest FFR wire and the third pressure guidewire it has introduced in the last three years. It represents Volcano's latest advancement in its goal of delivering the precision of FFR guidance with the utility of a frontline guidewire.

Volcano will highlight its broad portfolio of Precision Guided Therapy products in clinical, educational and technology showcases throughout TCT 2011, including:

  • Tuesday, November 8: 7:00 am - 8:00 am
    Breakfast Symposium - Treating the Complex Lesion: Techniques and Technology for Left Mains and Bifurcations
    Moscone Convention Center, Room 114
    Chair: David Rizik, MD; Faculty: John Hodgson, MD, Bon-Kwon Koo, MD
  • Wednesday, November 9: 10:00 am
    Edited Taped Case Presentation: Development and Application of instant wave-Free Ratio (iFR): A New Pressure-Derived Adenosine-Free Measure of Fractional Flow Reserve: A First-in-Man Showcase
    Presentation Theater North (Napa Valley), Moscone Center
    Operator: Justin Davies, MD, PhD
  • Thursday, November 10: 7:00 am - 8:00 am
    Breakfast Symposium - Breaking Down Barriers to FFR
    Adoption: Introducing iFR, a V
    '/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Volcano Reports 18 Percent Increase in Total Third Quarter Revenues
2. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
3. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
4. Volcano Corporation Announces Presentations at Upcoming Investor Conferences
5. Volcano Reports 22 Percent Increase in Second Quarter Medical Segment Revenues and Earnings per share of $0.09
6. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
7. Volcano Corporation Presentation at William Blair Conference to be Webcast
8. Volcano Corporation Presentation at Goldman Sachs Conference to be Webcast
9. Statement From Volcano Corporation on Latest St. Jude Lawsuit
10. Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR
11. Volcano Achieves 22 Percent Increase in First Quarter Revenues; Sales Growth, Margin Expansion Drive Profitability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Researchers from the North American Menopause Society (NAMS) found ... too high, 1 putting women at risk for ... close to menopause are commonly told to take supplements ... as osteoporosis, to which they are particularly prone. ... calcium they typically get through their food sources before ...
(Date:7/23/2014)... 2014 This September leading clinicians in orthodontics ... Vegas for DOCtalk 2014 —a "Dynamic ... thinker and private practitioner Dr. David Sarver , ... discuss clinical and practice management efficiency and high quality ... opportunity to welcome fresh thinking and join a community ...
(Date:7/23/2014)... 2014 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ... and research facility: Ampio Pharmaceuticals, 373 Inverness ... (720) 437-6500 Michael Macaluso , Ampio,s ... facility will be fully operational this summer, right ... Ampion TM necessary to accommodate the company,s BLA ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: ... a pharmaceutical company dedicated to improving healthcare through ... range of prescription and over-the-counter ("OTC") products, today ... Mr. Tony Liu and Chief Financial Officer, Ms. ...
... that a new market research report is available in ... in China http://www.reportlinker.com/p0363587/The-Top-10-CMOs-in-China.html ... and future outlook of CMO industry in China. It ... the top 10 CMOs. Other leading players are also ...
Cached Medicine Technology:American Oriental Bioengineering's CEO and CFO Visit the United States as Entrepreneur Representatives of President Hu Jintao's Delegation 2Reportlinker Adds The Top 10 CMOs in China 2
(Date:7/23/2014)... Battle Creek, MI (PRWEB) July 23, 2014 ... treatment program that gets clients off to a great ... they can believe in, has launched a new Internet ... , “Many people are surprised to learn that Internet ... sexual addiction or drug addiction, but that it’s trapping ...
(Date:7/23/2014)... Adipic acid is an intermediate chemical ... plastic, often referred to as engineering thermoplastics. These ... the monomers employed. Due to the high production ... increasing number of developing countries, the Asia-Pacific region ... by Europe and North America. Adipic acid in ...
(Date:7/23/2014)... 23, 2014 (HealthDay News) -- Children and teens who lose ... death in adulthood, a new study suggests. People who ... 50 percent greater risk of death during the study period ... parent, according to the report. Although the study found ... risk of premature death, it wasn,t designed to prove cause-and-effect. ...
(Date:7/23/2014)... ill patients arriving at the emergency department, the ... amnesia for rapid, life-saving intubation, despite decades-old studies ... results of a systematic review of 10 recent ... a "wonder drug" are published online in ... of Ketamine on Intracranial and Cerebral Perfusion Pressure ...
(Date:7/23/2014)... 2014 SafeUseNow? , a ... developed by Principled Strategies , today announced ... California . Utilizing SafeUseNow’s patent-pending risk model, Partnership ... misusing and abusing controlled substance drugs, particularly prescription ... its members. , The agreement with Partnership HealthPlan ...
Breaking Medicine News(10 mins):Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 2Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 3Health News:Partnership HealthPlan of California Signs Program Participation Agreement with SafeUseNow 4
... Bulgaria is to ban the imports of live birds, eggs ... reported suspected bird flu outbreaks. The first case of bird ... province near the Aegean Sea in Western Turkey. Following the ... being slaughtered in order to prevent the spread of the ...
... new study has linked beta-carotene to heart diseases. The ... of deaths in elderly with heart diseases. ,The ... significant after considering other risk factors, according to the ... previous studies that either suggest the carotenoid raises the ...
... novel initiative to combat the spread of childhood obesity, ... of the William J. Clinton Foundation and the American ... a partnership with Nickelodeon's award-winning Let's Just Play pro-social ... a comprehensive media and public awareness campaign, encouraging young ...
... nutritionally good compounds. Lot of research is being done ... herbs, fruits, and vegetables, slowed the growth of prostate ... ,Previous studies already found flavonoids (found in fruits and ... of cancers. ,The current study was intended to ...
... its major 29 hospitals to share information about its ... and interlinking of data would be helpful to citizen ... the case history and treatment provided to this patient. ... with different hospital departments. From a patient's personal information ...
... linked to a number of psychiatric disorders, including ... Early smoking is shown to increase the risk ... disorder, generalized anxiety disorder), and that presence of ... risk for later development of nicotine dependence. ...
Cached Medicine News:Health News:A New Initiative To Fight Childhood Obesity 2Health News:Prostate tumour growth suppressed by flavonoids 2Health News:Delhi Government To Interlink All Major Hospitals Through e-Governance 2Health News:Smokers Are Prone To Number Of Psychiatric Disorders 2
... injectable low osmolar, nonionic, contrast media ... biologically inert when injected intra-arterially. Each ... of ioversol, 3.6 mg of tromethamine ... of edetate calcium disodium as a ...
... is a non-ionic monomeric contrast medium for ... and children. After a decade of clinical ... examinations, IMAGOPAQUE has proven to be a ... hundreds of radiology departments.Results from large multicentre ...
... ProHance® (gadoteridol) is a contrast medium ... form of a sterile, apyrogenic solution for ... contrast enhancement of the brain, spine and ... with unenhanced MRI) of lesions with abnormal ...
... Advanced Magnetics' contrast agent for use with MRI ... the first organ-specific MRI contrast agent to be ... agent is taken up by macrophages found only ... tumors. The liver is a principal site for ...
Medicine Products: